Products & Patents held by the Mastitis Research Centre
Fundamentally we are seeking to achieve a quantum improvement in cure rates not just new products. We are respectful, but not daunted by this challenge, are pleased with the progress to date and proud of the following product in the market e.g.:
- Lactapen G™
- Cephaforte™
- Intercept™
The following patents are the results of our current research efforts.
- NZ 598443, Controlled Release Compositions and their Methods of Use, F. Al Alawi, O. Bork, I. G. Tucker, 2012
- NZ 601299, Injectable Antibiotic Formulations and Their Methods of Use, I. G. Tucker, O. Bork, F. Al Alawi, K. Nanjan, R. Jain, 2012